ニュージャージーにおける心不全の臨床試験
ニュージャージー内の拠点で、心不全に関する27件の研究が参加者を募集しています。
ニュージャージー内の都市
- Edison10件の研究
- Newark10件の研究
- Clifton8件の研究
- Camden8件の研究
- Trenton7件の研究
- Paterson4件の研究
- Pleasantville3件の研究
- Brick3件の研究
公式研究テキスト（英語）
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Jersey City
- Research Site, Somerset
被験者募集中第3相
18歳〜130歳 · 全性別 · 2026/10/02更新 · NCT06307652A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Advanced Heart Care, LLC, Bridgewater
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06935370A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Advanced Heart Care, LLC, Bridgewater
- Garden State Heart Care, PC, Manalapan
- Cardio Metabolic Institute, Somerset
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06424288A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Bridgewater
- Research Site, Millville
- Research Site, Sewell
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Advanced Heart Care, LLC, Bridgewater
- Monmouth Cardiology Associates, LLC, Eatontown
被験者募集中第3相
18歳〜85歳 · 全性別 · 2026/09/24更新 · NCT06736574Alleviant ALLAY-HFrEF Study
- Deborah Heart & Lung Center, Browns Mills
- Englewood Medical Center, Englewood
被験者募集中
18歳以上 · 全性別 · 2026/09/16更新 · NCT06812533Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Virtua Health Incorporated, Marlton
- Saint Michaels Medical Center, Newark
- CardioMetabolic Collaborative Clinic, Somerset
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/16更新 · NCT07037459Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Pennington
- Research Site, Somerset
被験者募集中第3相
40歳以上 · 全性別 · 2026/09/15更新 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Camden, NJ Investigative Site 10033, Camden
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06008197Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- Newark Beth Israel Medical Center, Newark
被験者募集中
18歳〜100歳 · 全性別 · 2026/09/09更新 · NCT06310031Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
- Morristown Medical Center, Morristown
被験者募集中
18歳以上 · 全性別 · 2026/09/04更新 · NCT07069738AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
- Morristown Medical Center, Morristown
被験者募集中第2相
40歳〜85歳 · 全性別 · 2026/08/27更新 · NCT06793371Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
- Hackensack University Medical Center, Hackensack
- Jersey Shore University Medical Center, Neptune City
被験者募集中
21歳以上 · 全性別 · 2026/08/25更新 · NCT05677100Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Eatontown
- Marlton
- Morristown
- 他2件
被験者募集中観察研究
全年齢 · 全性別 · 2026/08/20更新 · NCT00271180A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Hackensack University Medical Center, Hackensack
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/19更新 · NCT05489705A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Heart House - Vineland, Elmer
- Advanced Cardiology LLC - Hackettstown, Hackettstown
- The Heart House Haddon Heights, Haddon Heights
- 他5件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07567001Assessment of CCM in HF With Higher Ejection Fraction
- Our Lady of Lourdes, Camden
- Cooper Hospital- Cardiovascular Associates of Delaware Valley, Haddon Heights
- Atlantic Health System- Morristown Medical Center, Morristown
- 他1件
被験者募集中
18歳以上 · 全性別 · 2026/08/06更新 · NCT05064709Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Hackensack University Medical Center, Hackensack
- Newark Beth Israel Medical Center, Newark
被験者募集中
18歳以上 · 全性別 · 2026/06/10更新 · NCT06526195AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Hackensack University Medical Center, Hackensack
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/06/01更新 · NCT06699056The Salt Study for Heart Failure
- Robert Wood Johnson Barnabas Hospital - New Brunswick, New Brunswick
被験者募集中
18歳以上 · 全性別 · 2026/05/01更新 · NCT07560592CCM OPEN HF Registry
- Deborah Heart and Lung Center, Browns Mills
- Hackensack University Medical Center, Hackensack
- Rutgers New Jersey Medical School & University Hospital, Newark
被験者募集中観察研究
18歳以上 · 全性別 · 2026/04/23更新 · NCT07112924The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Deborah Heart & Lung, Browns Mills
- Hackensack University Medical Center, Edison
- St Michael/Prime Healthcare Services, Newark
被験者募集中
18歳以上 · 全性別 · 2026/04/13更新 · NCT03142152Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure
- Impulse Dynamics, Marlton
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/24更新 · NCT07209098His-Bundle Corrective Pacing in Heart Failure
- Valley Health System, Ridgewood
被験者募集中
18歳以上 · 全性別 · 2026/02/09更新 · NCT05265520Left vs Left Randomized Clinical Trial
- HMH Hospitals Corporation, Hackensack
- Virtua Health, Marlton
- Newark Beth Israel Medical Center, Newark
- 他1件
被験者募集中
18歳以上 · 全性別 · 2025/10/02更新 · NCT05650658Cardiogenic Shock Working Group Registry
- Hackensack Meridian Health, Hackensack
被験者募集中観察研究
18歳以上 · 全性別 · 2025/06/06更新 · NCT04682483ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。